Evidence map›Paper›PMID 29770436›Full record

ReviewFEBS letters2018

All I's on the RADAR: role of ADAR in gene regulation.

Galina Shevchenko, Kevin V Morris

Open access · greenAbstract readReview
In one paragraph

Review in FEBS letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Galina ShevchenkoHematological Malignancy and Stem Cell Transplantation Institute, Center for Gene Therapy, City of Hope-Beckman Research Institute, Duarte, CA, USA.
Kevin V MorrisHematological Malignancy and Stem Cell Transplantation Institute, Center for Gene Therapy, City of Hope-Beckman Research Institute, Duarte, CA, USA.
Beckman Research InstituteCity Of Hope National Medical Center · US

Funding

Targeted Delivery Vechicles for OligonucleotidesP01AI099783 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AKKINA, RAMESH · 2012 to 2016
$7.4M
Transcriptional control, targeted modification, and excision of HIV in the brainR01MH113407 · NIMH · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI BURNETT, JOHN CORY · 2017 to 2021
$3.0M
Targeted inhibition of HIV-1 latencyR01AI111139 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2014 to 2018
$2.7M
Activating cystic fibrosis transmembrane conductance regulator: the therapeutic potential of RNA directed gene activationR01DK104681 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2015 to 2019
$1.9M
NIAID NIH HHS P01 AI099783NIAID NIH HHS R01 AI111139NIDDK NIH HHS R01 DK104681NIMH NIH HHS R01 MH113407
6 · The paper itself

Abstract

Adenosine to inosine (A-to-I) editing is the most abundant form of RNA modification in mammalian cells, which is catalyzed by adenosine deaminase acting on the double-stranded RNA (ADAR) protein family. A-to-I editing is currently known to be involved in the regulation of the immune system, RNA splicing, protein recoding, microRNA biogenesis, and formation of heterochromatin. Editing occurs within regions of double-stranded RNA, particularly within inverted Alu repeats, and is associated with many diseases including cancer, neurological disorders, and metabolic syndromes. However, the significance of RNA editing in a large portion of the transcriptome remains unknown. Here, we review the current knowledge about the prevalence and function of A-to-I editing by the ADAR protein family, focusing on its role in the regulation of gene expression. Furthermore, RNA editing-independent regulation of cellular processes by ADAR and the putative role(s) of this process in gene regulation will be discussed.

Indexed as

AdenosineAdenosine DeaminaseAlu ElementsAnimalsGene Expression RegulationHeterochromatinHumansInosineMicroRNAsRNA, Double-StrandedRNA EditingRNA SplicingAdenosineAdenosine DeaminaseHeterochromatinInosineMicroRNAsRNA, Double-StrandedADARadenosine to inosinenon-coding RNARNA editing

Identifiers

PMID29770436
PMCPMC6327961
OpenAlexW2804067982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.